Comparison of risk of malignancy and predictive value of diagnostic categories defined by Papanicolaou Society of Cytopathology system and WHO reporting system for pancreaticobiliary cytopathology in solid pancreatic lesions.

EUS-FNA Papanicolaou classification pancreatic cancer risk of malignancy

Journal

Therapeutic advances in gastroenterology
ISSN: 1756-283X
Titre abrégé: Therap Adv Gastroenterol
Pays: England
ID NLM: 101478893

Informations de publication

Date de publication:
2024
Historique:
received: 27 02 2024
accepted: 25 06 2024
medline: 8 10 2024
pubmed: 8 10 2024
entrez: 8 10 2024
Statut: epublish

Résumé

The standardized diagnostic categories defined by the World Health Organization (WHO) reporting system support the interdisciplinary interpretation of cytological findings in the management of pancreatic cancer. To compare this classification to the Papanicolaou Society of Cytopathology (PSC) system in terms of predictive value and risk of malignancy (ROM) in solid pancreatic lesions. Retrospective cohort study. All consecutive patients with solid pancreatic lesions who underwent endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) sampling at the University of Szeged from 2014 to 2021 were retrospectively enrolled. The predictive value and ROM of cytological findings were determined with comparison to histologic outcome and/or clinical follow-up. A total of 521 EUS-FNAs were performed with a malignancy rate of 81.76%. In both classification systems, the absolute ROM of "non-diagnostic," "negative for malignancy," "atypical," "suspicious for malignancy," and "malignant" categories were 48.2%, 2.3%, 78.1%, 100.0%, and 99.4%, respectively. Despite the heterogeneous nature of the "neoplastic: other" category of the PSC system, the absolute ROM for solid lesions was 100%. Pancreatic neoplasm: high-risk/grade category including only two endosonographically solid cases of high-grade intraductal papillary mucinous neoplasms showed 100% ROM. There were no differences between PSC and WHO systems in sensitivity, specificity, and negative and positive predictive values: excluding the "atypical" category, these were 99.7%, 95.6%, 97.7%, and 99.5%, respectively. The "atypical" category considered benign resulted in a higher decrease in validity and negative predictive value, compared to "atypical" considered true malignant (93.6% vs 97.7% and 65.8% vs 97.7%). For solid pancreatic lesions, the WHO system was identical to the PSC system in terms of ROM and predictive values.

Sections du résumé

Background UNASSIGNED
The standardized diagnostic categories defined by the World Health Organization (WHO) reporting system support the interdisciplinary interpretation of cytological findings in the management of pancreatic cancer.
Objective UNASSIGNED
To compare this classification to the Papanicolaou Society of Cytopathology (PSC) system in terms of predictive value and risk of malignancy (ROM) in solid pancreatic lesions.
Design UNASSIGNED
Retrospective cohort study.
Methods UNASSIGNED
All consecutive patients with solid pancreatic lesions who underwent endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) sampling at the University of Szeged from 2014 to 2021 were retrospectively enrolled. The predictive value and ROM of cytological findings were determined with comparison to histologic outcome and/or clinical follow-up.
Results UNASSIGNED
A total of 521 EUS-FNAs were performed with a malignancy rate of 81.76%. In both classification systems, the absolute ROM of "non-diagnostic," "negative for malignancy," "atypical," "suspicious for malignancy," and "malignant" categories were 48.2%, 2.3%, 78.1%, 100.0%, and 99.4%, respectively. Despite the heterogeneous nature of the "neoplastic: other" category of the PSC system, the absolute ROM for solid lesions was 100%. Pancreatic neoplasm: high-risk/grade category including only two endosonographically solid cases of high-grade intraductal papillary mucinous neoplasms showed 100% ROM. There were no differences between PSC and WHO systems in sensitivity, specificity, and negative and positive predictive values: excluding the "atypical" category, these were 99.7%, 95.6%, 97.7%, and 99.5%, respectively. The "atypical" category considered benign resulted in a higher decrease in validity and negative predictive value, compared to "atypical" considered true malignant (93.6% vs 97.7% and 65.8% vs 97.7%).
Conclusion UNASSIGNED
For solid pancreatic lesions, the WHO system was identical to the PSC system in terms of ROM and predictive values.

Identifiants

pubmed: 39377014
doi: 10.1177/17562848241271958
pii: 10.1177_17562848241271958
pmc: PMC11457282
doi:

Types de publication

Journal Article

Langues

eng

Pagination

17562848241271958

Informations de copyright

© The Author(s), 2024.

Déclaration de conflit d'intérêts

The authors declare that there is no conflict of interest.

Auteurs

Béla Vasas (B)

Department of Pathology, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary.

Anna Fábián (A)

Department of Internal Medicine, Center for Gastroenterology, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary.

Zsófia Bősze (Z)

Department of Internal Medicine, Center for Gastroenterology, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary.

Sándor Hamar (S)

Department of Pathology, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary.

László Kaizer (L)

Department of Pathology, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary.

Tibor Tóth (T)

Department of Internal Medicine, Center for Gastroenterology, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary.

Péter Bacsur (P)

Department of Internal Medicine, Center for Gastroenterology, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary.

Tamás Resál (T)

Department of Internal Medicine, Center for Gastroenterology, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary.

Anita Bálint (A)

Department of Internal Medicine, Center for Gastroenterology, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary.

Klaudia Farkas (K)

Department of Internal Medicine, Center for Gastroenterology, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary.

Tamás Molnár (T)

Department of Internal Medicine, Center for Gastroenterology, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary.

Zoltán Szepes (Z)

Department of Internal Medicine, Center for Gastroenterology, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary.

Renáta Bor (R)

Department of Internal Medicine, Center for Gastroenterology, Albert Szent-Györgyi Clinical Center, University of Szeged, Kálvária sgt. 57, Szeged 6725, Hungary.

Classifications MeSH